S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)

STAAR Surgical (STAA) Stock Forecast, Price & News

$39.41
+0.02 (+0.05%)
(As of 09/22/2023 ET)
Compare
Today's Range
$39.16
$40.66
50-Day Range
$39.39
$57.72
52-Week Range
$39.12
$81.81
Volume
372,163 shs
Average Volume
775,796 shs
Market Capitalization
$1.91 billion
P/E Ratio
78.82
Dividend Yield
N/A
Price Target
$58.50

STAAR Surgical MarketRank™ Forecast

Analyst Rating
Hold
2.42 Rating Score
Upside/​Downside
48.4% Upside
$58.50 Price Target
Short Interest
Bearish
13.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.20mentions of STAAR Surgical in the last 14 days
Based on 16 Articles This Week
Insider Trading
Acquiring Shares
$9.87 M Bought Last Quarter
Proj. Earnings Growth
48.08%
From $0.52 to $0.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.02 out of 5 stars

Medical Sector

31st out of 968 stocks

Ophthalmic Goods Industry

1st out of 7 stocks


STAA stock logo

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA Price History

STAA Stock News Headlines

Out Of This World Stock Alerts!
There Is This One Lithium Stock That Has Our Full Attention! Sign Up And Learn More!
STAAR Surgical (NASDAQ:STAA) Rating Lowered to Hold at Benchmark
STAAR Surgical (NASDAQ:STAA) Downgraded by Benchmark
Out Of This World Stock Alerts!
There Is This One Lithium Stock That Has Our Full Attention! Sign Up And Learn More!
STAAR Surgical (NASDAQ:STAA) Downgraded by StockNews.com
STAAR Surgical (NASDAQ:STAA) Shares Gap Down After Analyst Downgrade
STAAR Surgical's (STAA) "Buy" Rating Reiterated at Mizuho
STAAR Surgical's (STAA) "Hold" Rating Reaffirmed at Stifel Nicolaus
BTIG Sticks to Their Hold Rating for Staar Surgical (STAA)
8 Analysts Have This to Say About Staar Surgical
BTIG Reaffirms Their Hold Rating on Staar Surgical (STAA)
Staar Surgical Co (STAA): A Potential Value Trap?
What 9 Analyst Ratings Have To Say About Staar Surgical
See More Headlines
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Company Calendar

Last Earnings
8/02/2023
Today
9/22/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
882
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$58.50
High Stock Price Forecast
$88.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+48.4%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
12 Analysts

Profitability

Net Income
$38.76 million
Pretax Margin
10.38%

Debt

Sales & Book Value

Annual Sales
$284.39 million
Cash Flow
$0.86 per share
Book Value
$6.89 per share

Miscellaneous

Free Float
47,967,000
Market Cap
$1.91 billion
Optionable
Optionable
Beta
1.09

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Thomas G. Frinzi (Age 67)
    Pres, CEO & Chairman
    Comp: $94.48k
  • Mr. Patrick F. WilliamsMr. Patrick F. Williams (Age 50)
    Chief Financial Officer
    Comp: $959.99k
  • Dr. Keith Holliday Ph.D. (Age 60)
    Chief Technology Officer
    Comp: $829.09k
  • Mr. James Francese (Age 59)
    Sr. VP of Commercial Operations - North America & APAC
    Comp: $755.65k
  • Ms. Caren L. MasonMs. Caren L. Mason (Age 69)
    Advisor
    Comp: $1.95M
  • Dr. Scott D. Barnes M.D. (Age 61)
    Chief Medical Officer
    Comp: $828.3k
  • Mr. Warren Foust (Age 47)
    Chief Operating Officer
  • Mr. Brian Moore
    VP of Investor, Media Relations & Corp. Devel.
  • Mr. Samuel J. GestenMr. Samuel J. Gesten (Age 61)
    Chief Legal Officer & Corp. Sec.
  • Dr. Magda Michna Ph.D.
    Chief Clinical, Regulatory & Medical Affairs Officer













STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View STAA analyst ratings
or view top-rated stocks.

What is STAAR Surgical's stock price forecast for 2023?

12 brokerages have issued twelve-month price targets for STAAR Surgical's shares. Their STAA share price forecasts range from $40.00 to $88.00. On average, they anticipate the company's stock price to reach $58.50 in the next twelve months. This suggests a possible upside of 48.4% from the stock's current price.
View analysts price targets for STAA
or view top-rated stocks among Wall Street analysts.

How have STAA shares performed in 2023?

STAAR Surgical's stock was trading at $48.54 at the beginning of 2023. Since then, STAA stock has decreased by 18.8% and is now trading at $39.41.
View the best growth stocks for 2023 here
.

When is STAAR Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our STAA earnings forecast
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, August, 2nd. The medical instruments supplier reported $0.23 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.04. The medical instruments supplier had revenue of $92.31 million for the quarter, compared to analysts' expectations of $93.04 million. STAAR Surgical had a net margin of 8.14% and a trailing twelve-month return on equity of 8.37%.

What ETFs hold STAAR Surgical's stock?
What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical issued an update on its FY 2026 earnings guidance on Thursday, September, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$550.00 million.

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.07%), Baillie Gifford & Co. (10.57%), State Street Corp (3.62%), Jackson Square Partners LLC (2.83%), Geode Capital Management LLC (2.06%) and Geneva Capital Management LLC (1.97%). Insiders that own company stock include Aimee S Weisner, Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends
.

How do I buy shares of STAAR Surgical?

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $39.41.

How much money does STAAR Surgical make?

STAAR Surgical (NASDAQ:STAA) has a market capitalization of $1.91 billion and generates $284.39 million in revenue each year. The medical instruments supplier earns $38.76 million in net income (profit) each year or $0.50 on an earnings per share basis.

How many employees does STAAR Surgical have?

The company employs 882 workers across the globe.

Does STAAR Surgical have any subsidiaries?
The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -